Results 231 to 240 of about 235,919 (281)
Measurement and Evaluation of Restitution Characteristics of Golf Balls.
Sadayuki UJIHASHI +3 more
openalex +2 more sources
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez +12 more
wiley +1 more source
Restitution or substitution after loss of a human hand: A personal view. [PDF]
Kay SPJ.
europepmc +1 more source
Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
The importance of saying sorry when things go wrong in health care. [PDF]
Patrick K.
europepmc +1 more source
Evaluation des risques liés à l'immersion des boues de dragage des ports maritimes. Colloque de restitution des résultats du programme PNETOX, Paris 3 et 4 octobre 2002 [PDF]
Claude Alzieu +9 more
openalex
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Mathematical Framework for the Representation of the Travel of an Accelerometer-Based Texture Testing Device. [PDF]
Paulsen H +3 more
europepmc +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source

